Cellromax Science Co., Ltd. Logo

Cellromax Science Co., Ltd.

Develops health foods, derma-cosmetics, and OTC drugs for pharmacies and online channels.

471820 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 구성로 357 D동 710호 (청덕동, 용인테크노밸리), 용인시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cellromax Science Co., Ltd. is a KOSDAQ-listed company specializing in the development, manufacturing, and distribution of health-oriented products. Its primary business divisions include health functional foods, derma-cosmetics, and over-the-counter (OTC) pharmaceuticals. The company focuses on creating differentiated products through dedicated research, using carefully selected natural-origin raw materials and optimal formulation science. Key product features include specialized prescriptions and user-friendly formulation technology. Cellromax Science distributes its products through pharmacies and direct-to-consumer online channels. The company was formerly known as Pharmacist & Health Co., Ltd. and rebranded in 2021.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Cellromax Science Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-12 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (분기배당)
Korean 8.1 KB
2025-09-12 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.5 KB
2025-09-01 00:00
Share Issue/Capital Change
감자완료
Korean 8.9 KB
2025-08-27 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-13 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(감자결정)
Korean 22.5 KB
2025-08-12 00:00
Share Issue/Capital Change
[기재정정]전환청구권행사 (제1회차)
Korean 11.8 KB

Automate Your Workflow. Get a real-time feed of all Cellromax Science Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cellromax Science Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
VENTURE LIFE GROUP PLC Logo
Develops, manufactures, and distributes consumer self-care products and medical devices globally.
United Kingdom VLG
Vetoquinol SA Logo
Develops and markets veterinary drugs and products for companion animals and livestock worldwide.
France VETO
Vifor Pharma AG Logo
A global leader in specialty pharmaceuticals for iron deficiency and nephrology.
Switzerland VIFN
ViGenCell Inc. Logo
Developing T-cell immune therapies to treat cancer and other incurable diseases.
South Korea 308080
Virbac Logo
Develops animal health pharma, vaccines & diagnostics for vets, farmers & pet owners globally.
France FR000
ViroGates A/S Logo
Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.
Denmark VIRO
Vistin Pharma Logo
A leading global producer of Metformin Hydrochloride for the global healthcare market.
Norway VISTN
Vita 34 AG Logo
A cell bank storing umbilical cord stem cells as biological insurance for families' future health.
Germany V3V
Vivoryon Therapeutics N.V. Logo
Developing first-in-class small molecule therapies for age-related and kidney diseases.
Germany VVY
Develops innovative, non-narcotic drugs for pain and central nervous system (CNS) diseases.
South Korea 082800

Talk to a Data Expert

Have a question? We'll get back to you promptly.